1. Home
  2. ALT vs MLP Comparison

ALT vs MLP Comparison

Compare ALT & MLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • MLP
  • Stock Information
  • Founded
  • ALT 1997
  • MLP 1909
  • Country
  • ALT United States
  • MLP United States
  • Employees
  • ALT N/A
  • MLP N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • MLP Real Estate
  • Sector
  • ALT Health Care
  • MLP Finance
  • Exchange
  • ALT Nasdaq
  • MLP Nasdaq
  • Market Cap
  • ALT 472.3M
  • MLP 411.7M
  • IPO Year
  • ALT N/A
  • MLP 1972
  • Fundamental
  • Price
  • ALT $5.28
  • MLP $17.98
  • Analyst Decision
  • ALT Strong Buy
  • MLP
  • Analyst Count
  • ALT 8
  • MLP 0
  • Target Price
  • ALT $20.83
  • MLP N/A
  • AVG Volume (30 Days)
  • ALT 2.5M
  • MLP 13.8K
  • Earning Date
  • ALT 05-08-2025
  • MLP 03-27-2025
  • Dividend Yield
  • ALT N/A
  • MLP N/A
  • EPS Growth
  • ALT N/A
  • MLP N/A
  • EPS
  • ALT N/A
  • MLP N/A
  • Revenue
  • ALT $20,000.00
  • MLP $12,196,000.00
  • Revenue This Year
  • ALT N/A
  • MLP N/A
  • Revenue Next Year
  • ALT N/A
  • MLP N/A
  • P/E Ratio
  • ALT N/A
  • MLP N/A
  • Revenue Growth
  • ALT N/A
  • MLP 34.84
  • 52 Week Low
  • ALT $5.15
  • MLP $17.02
  • 52 Week High
  • ALT $11.50
  • MLP $26.46
  • Technical
  • Relative Strength Index (RSI)
  • ALT 38.48
  • MLP 34.56
  • Support Level
  • ALT $5.15
  • MLP $17.02
  • Resistance Level
  • ALT $6.09
  • MLP $19.91
  • Average True Range (ATR)
  • ALT 0.42
  • MLP 0.68
  • MACD
  • ALT -0.05
  • MLP -0.19
  • Stochastic Oscillator
  • ALT 24.54
  • MLP 27.95

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About MLP Maui Land & Pineapple Company Inc.

Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales: , which includes land planning and entitlement, development, and sales activities.; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.

Share on Social Networks: